IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
36 hedge funds and large institutions have $141M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
Holders
36
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$1.34M | |
| 3 | +$1.28M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$1.16M |
| 5 |
LM
Lasry Marc
|
+$730K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.29M | |
| 3 | -$434K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$370K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$177K |